OTCMKTS:GNGBY - Getinge Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$36.45
+0.30 (1.20%)

This chart shows the closing price for GNGBY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Getinge Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GNGBY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GNGBY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Getinge in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $36.45.

This chart shows the closing price for GNGBY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 8 investment analysts is to buy stock in Getinge. This rating has held steady since August 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/25/2021Jefferies Financial GroupInitiated CoverageBuy
4/21/2021JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral
4/13/2021DNB MarketsUpgradeHold ➝ Buy
3/11/2021SEB Equity ResearchUpgradeHold ➝ Buy
3/11/2021SEB EquitiesUpgradeHold ➝ Buy
2/10/2021Berenberg BankReiterated RatingBuy
2/1/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
12/9/2020Morgan StanleyReiterated RatingEqual Weight
10/19/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
9/16/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
9/9/2020Bank of AmericaInitiated CoverageBuy
8/7/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
7/31/2020Morgan StanleyReiterated RatingEqual Weight
7/20/2020Berenberg BankReiterated RatingBuy
6/17/2020Berenberg BankReiterated RatingBuy
6/12/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
4/23/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
4/17/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
(Data available from 6/21/2016 forward)
Getinge logo
Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, and logistic automation solutions; practice-oriented monitoring systems and disposables, vascular and cardiothoracic surgery solutions, anesthesia machines, beating heart surgery solutions, ceiling supply units, connected solutions, and indicators, as well as washer-disinfectors, consumables, and IT-solutions. The company also provides endovascular products; chest drain products; endoscope reprocessing; endoscopic vessel harvesting systems; ventilators; extracorporeal life support or extracorporeal membrane oxygenation products; intra-aortic balloon counter pulsation therapies; operating lights; and modular room systems. In addition, it offers operating tables and accessories; operating room (OR) furniture; OR integration systems; OR management solutions; loading and distribution trolleys; patient flow management and transport solutions; sealing equipment; sterile supply management and traceability solutions; surgical perfusion components; surgical assist systems; and trays and baskets, as well as inspection and packaging and after sales consulting services. Further, the company provides professional financial advisory services to hospitals and medical facilities; and education and training services. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.
Read More

Today's Range

Now: $36.45
Low: $36.45
High: $36.45

50 Day Range

MA: $34.28
Low: $29.83
High: $37.81

52 Week Range

Now: $36.45
Low: $18.49
High: $37.81

Volume

70 shs

Average Volume

1,648 shs

Market Capitalization

$9.26 billion

P/E Ratio

27.41

Dividend Yield

0.71%

Beta

0.88

Frequently Asked Questions

What sell-side analysts currently cover shares of Getinge?

The following Wall Street research analysts have issued reports on Getinge in the last twelve months: Bank of America Co., Berenberg Bank, DNB Markets, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, SEB Equities, and SEB Equity Research.
View the latest analyst ratings for GNGBY.

What is the current price target for Getinge?

0 Wall Street analysts have set twelve-month price targets for Getinge in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Getinge in the next year.
View the latest price targets for GNGBY.

What is the current consensus analyst rating for Getinge?

Getinge currently has 2 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GNGBY will outperform the market and that investors should add to their positions of Getinge.
View the latest ratings for GNGBY.

What other companies compete with Getinge?

How do I contact Getinge's investor relations team?

Getinge's physical mailing address is LINDHOLMSPIREN 7A, GOTHENBURG V7, 41756. The company's listed phone number is 46-1-033-500-00 and its investor relations email address is [email protected] The official website for Getinge is www.getinge.com.